CTRI/2020/10/028675
Not yet recruiting
未知
Clinical and immunological factors predicting relapse in patients with pemphigustreated with rituximab: A prospective cohort study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- All India Institute of Medical Sciences
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with confirmed pemphigus vulgaris or foliaceus treated with RTX\- RA protocol.
Exclusion Criteria
- •1\. Patients who have received RTX cycles in the preceding one year.
- •2\. Patients with other concomitant autoimmune diseases.
- •3\. Pregnant and lactating patients.
- •4\. Patients who cannot come for follow up visits for at least 18 months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000047162Kobe University114
Completed
Not Applicable
Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Normal Mucosalcerative colitisJPRN-UMIN000029800Kitasato University Kitasato Institute Hospital150
Active, not recruiting
Phase 1
A study searching for the factors predicting ketamine´s antidepressant effectEUCTR2018-001539-39-CZárodní ústav duševního zdraví40
Completed
Not Applicable
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell LymphomaDiffuse Large B-cell LymphomaNCT01369784Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea158
Unknown
Not Applicable
Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung CancerLung CancerNCT04918836University Hospital, Brest150